Amyloid plaques found in the retinas of eyes may be an indicator of similar plaques in the brain, a hallmark of Alzheimer’s disease, and may provide a more visible biomarker for detecting disease risk.
Related Articles

News
Visa Concerns Deter Foreign-Born PhDs from Working in Startups
August 5, 2019
sandiegobiotech
News
Comments Off on Visa Concerns Deter Foreign-Born PhDs from Working in Startups

Industry News
UC San Diego to Partner with New Allen Institute for Immunology
December 12, 2018
sandiegobiotech
Industry News, News
Comments Off on UC San Diego to Partner with New Allen Institute for Immunology

News
UC San Diego Helps Expand Parkinson’s Progression Markers Initiative
December 6, 2021
sandiegobiotech
News
Comments Off on UC San Diego Helps Expand Parkinson’s Progression Markers Initiative
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023. Click here to view original post… […]